KA87

ICD-11 MMS 2026-01

Neonatal hyperbilirubinaemia

Description

A condition characterised as an increased level of bilirubin above 85 µmol/l (5 mg/dL) which manifests as yellowing of the eyes, skin, and other tissues of a newborn due to excessive break-down of red blood cells for any other reason not classified elsewhere.

Coding note from above levels

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Excludes

  • KA84.0 – jaundice due to isoimmunization

Exclusions from above levels

  • 3A10 – Hereditary haemolytic anaemia
  • 5C58.00 – Crigler-Najjar syndrome
  • 5C58.01 – Gilbert syndrome
Show allHide
  • 5C58.02 – Dubin-Johnson syndrome
  • LB20.22 – Congenital stenosis or stricture of bile ducts
  • 01 – Certain infectious or parasitic diseases - acquired after birth
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Child codes

  • KA87.0 – Neonatal hyperbilirubinaemia due to swallowed maternal blood
  • KA87.1 – Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation
  • KA87.2 – Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation
  • KA87.3 – Neonatal hyperbilirubinaemia due to total parenteral nutrition
  • KA87.4 – Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother
  • KA87.5 – Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn
  • KA87.6 – Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage
  • KA87.Y – Other specified neonatal hyperbilirubinaemia
  • KA87.Z – Neonatal hyperbilirubinaemia, unspecified

Sibling codes

  • KA80 – Fetal blood loss
  • KA81 – Umbilical haemorrhage of newborn
  • KA82 – Intracranial nontraumatic haemorrhage of fetus or newborn
  • KA83 – Certain specified neonatal haemorrhages
  • KA84 – Haemolytic disease of fetus or newborn
  • KA85 – Hydrops fetalis due to haemolytic disease
  • KA86 – Neonatal kernicterus
  • KA88 – Disseminated intravascular coagulation of fetus or newborn
  • KA89 – Transient neonatal thrombocytopaenia
  • KA8A – Polycythaemia neonatorum
  • KA8B – Anaemia of prematurity
  • KA8C – Congenital hypoplastic anaemia
  • KA8D – Transient neonatal neutropaenia
  • KA8E – Alloimmune neonatal neutropaenia
  • KA8F – Neonatal vitamin K deficiency
  • KA8Y – Other specified haemorrhagic or haematological disorders of fetus or newborn
  • KA8Z – Haemorrhagic or haematological disorders of fetus or newborn, unspecified

Foundation entity

Neonatal hyperbilirubinaemia – http://id.who.int/icd/entity/628615515

Part of: 19: Certain conditions originating in the perinatal period